Gender Disparities in Access to HIV Testing and Antiretroviral Treatment Services by Smith, Wyatt Lombard
SIT Graduate Institute/SIT Study Abroad
SIT Digital Collections
Independent Study Project (ISP) Collection SIT Study Abroad
Fall 2013
Gender Disparities in Access to HIV Testing and
Antiretroviral Treatment Services
Wyatt Lombard Smith
SIT Study Abroad
Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection
Part of the Family, Life Course, and Society Commons, Health Policy Commons, Health Services
Administration Commons, Immune System Diseases Commons, Inequality and Stratification
Commons, Medicine and Health Commons, and the Public Health Education and Promotion
Commons
This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for
inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please
contact digitalcollections@sit.edu.
Recommended Citation
Smith, Wyatt Lombard, "Gender Disparities in Access to HIV Testing and Antiretroviral Treatment Services" (2013). Independent
Study Project (ISP) Collection. 1687.
https://digitalcollections.sit.edu/isp_collection/1687
1 
Gender Disparities in Access to 
HIV Testing and Antiretroviral 
Treatment Services  
 
 
 
Wyatt Lombard Smith 
 
 
 
 
Project Advisor: Dr. Paul Muwanguzi 
Academic Director: Dr. Charlotte Mafumbo 
 
School for International Training 
University of Notre Dame 
 
Kampala, Uganda 
Naggalama, Uganda 
 
 
Fall 2013 
 
 
 
 
2 
Table of Contents 
 
ACKNOWLEDGEMENTS.................................... ....................... .3 
ABSTRACT……………………………………………………………………..4 
ABBREVIATIONS…………………………………………………………….6 
INTRODUCTION……………………………………………………………..7 
BACKGROUND……………………………………….……………………….8 
 HIV/AIDS IN UGANDA………………………………………………………………8 
 ANTIRETROVIRAL TREATMENT……………………………………………….10 
 MALE CIRCUMCISION PROGRAMS……………………………………………13 
JUSTIFICATION…………………………………………………………....14 
STATEMENT OF OBJECTIVES………………………………………...14 
METHODOLOGY................................................. ............. ...... ..15 
 OVERVIEW........................................................................................................15 
STUDY POPULATION AND SAMPLING.......................................................15 
INCLUSION AND EXCLUSION......................................................................16 
VARIABLES.......................................................................................................17 
PROCEDURE.....................................................................................................18 
OBSERVATION.................................................................................................18 
FOCUS GROUP DISCUSSIONS......................................................................19 
 FORMAL AND INFORMAL INTERVIEWS....................................................19 
 STATISTICAL ANALYSIS................................................................................20 
 CHALLENGES AND BIASES...........................................................................21 
STATEMENT OF ETHICS................................................................................22 
RESULTS........ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .........................23 
MORTALITY......................................................................................................23 
DIFFERENCES IN MORTALITY EXPLAINED BY LATE INITIATION.....25 
FINDINGS AND DISCUSSION............................... ..................28 
REASONS AND MOTIVES FOR HIV TESTING............................................29 
ANTIRETROVIRAL TREATMENT SERVICES..............................................31 
MALE CIRCUMCISION PROGRAMS.............................................................33 
RURAL VS. URBAN COMPARISON................................................................35 
CONCLUSIONS........ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .36 
RECOMMENDATIONS........................................... ..................38 
BIBLIOGRAPHY........ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41 
APPENDIX..............................................................................43 
 
 
 
 
 
 
3 
Acknowledgements 
 
 
 
I would like to thank Dr. Charlotte Mafumbo for her never-ending guidance and 
support on this project. This project would not have been possible without her wisdom 
and generosity throughout this entire program. I would also like to thank the staff at The 
AIDS Support Organisation (TASO) and St. Francis Naggalama Hospital for their 
knowledge and outstanding facilities. I would like to thank Dr. Simon Sentumbwe for his 
input and support in this project and I would also like to thank my interpreters for an 
incredible job in eliminating the language barrier between the participants and the 
researcher. Finally, I would like to extend thanks to Dr. Paul Muwanguzi for his 
continuous input and support as my Academic Advisor and guide during this practicum 
period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
Abstract 
 
Throughout a six-week practicum period at TASO Mulago in Kampala, Uganda 
and St. Francis Naggalama Hospital in Naggalama, Uganda, the researcher aimed to find 
methods to increase male engagement in all facets of comprehensive HIV/AIDS care. 
Women and children generally receive most global attention on the issue of HIV/AIDS in 
Uganda but men are beginning to demand more attention. Antiretroviral treatment has 
been critical in allowing countless people to live functionally with HIV but many 
research projects have hypothesized that delayed access to HIV/AIDS treatment and 
prevention methods has resulted in men exhibiting higher mortality rates upon initiation 
of this treatment. The disparity in men’s reception to this treatment puts the effectiveness 
of this and many other aspects of comprehensive HIV/AIDS treatment into question.  
Through statistical analysis, observation, formal and informal interviews, and 
focus group discussions the researcher aimed to test the hypotheses that men are much 
more likely to die when they initiate antiretroviral treatment than women and that this 
higher mortality rate results from later initiation of treatment characterized by CD4 cell 
count and WHO disease stage number. Through statistical analysis the researcher 
established the mortality rate as 16.485 deaths per 1000 men and 11.13 deaths per women 
at TASO Mulago and 69.444 deaths per 1000 men and 23.809 deaths per 1000 women at 
St. Francis Naggalama Hospital, proving the hypothesis that men have a higher mortality 
rate upon initiation of ART.  Significant differences in CD4 cell counts and WHO disease 
stage numbers proves the hypothesis that this higher mortality rate is a result of later 
initiation of ART.  
Through qualitative data the researcher found that women are required to test for 
HIV at early signs of pregnancy and through antenatal care but men have no similar 
avenue to test for HIV and as a result they only test for HIV as a result of grave illness 
brought about by a weakened immune system characteristic of high HIV prevalence. Men 
are also highly stigmatized by social forces that further exaggerate gender differences in 
access to HIV/AIDS care and support. The researcher proposes enhanced male 
circumcision programs to serve as avenues for men to engage in all facets of 
5 
comprehensive HIV/AIDS care. Through these programs men would gain education and 
encouragement to join in the fight against this epidemic.  
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Introduction 
  
 On their website, UNAIDS defines their program as “an innovative partnership 
that leads and inspires the world in achieving universal access to HIV prevention, 
treatment, care and support.1” The values established in this statement are critical in 
combating the prevalence of this virus and syndrome from our planet and for the country 
of Uganda these values must be swiftly implemented to create change on this issue. Much 
global research and attention has been directed to the problem of HIV/AIDS in Uganda 
but this condition continues to threaten the health and well being of many of the citizens 
of this country. Much of this attention is directed towards mothers and children, 
especially in the prevention of mother to child transmission of this virus (PMTCT).2 
While women and children are generally considered more vulnerable, men also play a 
significant role in the spread of HIV/AIDS and are starting to demand more attention on 
this matter.  
 Antiretroviral therapy, defined as “the combination of at least three 
antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression 
of HIV disease,” has allowed many individuals infected with the human 
immunodeficiency virus to live functional lives despite the tragic effects that this virus 
can pose on the human body3. Current research dictates, however, that men are beginning 
to exhibit higher mortality rates upon initiation of antiretroviral treatment than women.4 
This hypothesis is driven by the notion that men begin treatment later than women, 
resulting in a higher prevalence of the human immunodeficiency virus and a lower 
                                                
1 UNAIDS. (2012) About UNAIDS. Retrieved from 
http://www.unaids.org/en/aboutunaids/ 
2 UNICEF. (2013 September 5) Children and HIV and AIDS. Retrieved from 
http://www.unicef.org/aids/index_preventionyoung.html 
3 WHO. (2013) Antiretroviral therapy. Retrieved from 
http://www.who.int/hiv/topics/treatment/art/en/index.html 
4 Mills, E., Beyrer, C., Birungi, J., & Dybul, M. (2012 February 7). Engaging Men in 
Prevention and Care for HIV/AIDS in Africa. PLOS Medicine. Retrieved from 
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001167 
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prevalence of CD4 cells, the cells essential for a functioning immune system. Universal 
access to HIV treatment and prevention can only be accomplished by greater involvement 
of men in these practices that have been successful in reducing the prevalence of 
HIV/AIDS and helping people live functionally with HIV. Targeting men in the fight 
against HIV/AIDS is critical to combating HIV transmission and infection in Uganda and 
eliminating HIV/AIDS from Uganda requires a holistic approach including focus on men, 
women, and children together.  
 This project sought to test the hypotheses that men have a higher mortality rate 
than women upon initiation of antiretroviral treatment and that men begin antiretroviral 
treatment at later stages of HIV infection than women. This project also studied the 
effects of this lack of attention towards men in Uganda further to propose methods to 
further include men in the scope of global research to holistically combat the prevalence 
of HIV/AIDS in this country. The researcher conducted this study in TASO Mulago in 
Kampala, Uganda and St. Francis Naggalama Hospital in Naggalama, Uganda from 
October 21, 2013 to December 1, 2013 over a six-week period to compare how these 
issues are addressed in rural and urban settings. The study used qualitative data from 
focus group discussions, formal and informal interviews, and field observations as well as 
quantitative data from the databases of TASO Mulago and St. Francis Naggalama 
Hospital. 
 
Background 
 
HIV/AIDS in Uganda  
 
 According to statistics presented by UNAIDS in 2012, approximately 7.2% of 
the population of Uganda currently lives with the human immunodeficiency virus and 
approximately 150,000 people in Uganda become infected with HIV every year. These 
statistics also estimate that 62,000 people die from complications of AIDS in Uganda 
every year5. According to the 2011 Uganda AIDS Indicator Survey, HIV is most 
                                                
5 UNAIDS. (2012). HIV and AIDS Estimates in Uganda Retrieved from 
http://www.unaids.org/en/regionscountries/countries/uganda/ 
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prevalent in the Central 1 region (10.6%) and the Central 2 region (9.0%).6 The map in 
the appendix illustrates this data further (see appendix A). TASO Mulago is located in an 
urban setting in Kampala, Uganda, receiving clients from the Central 1 Region and St. 
Francis Naggalama Hospital is located in a rural setting in the Mukono District and 
receives clients from the Central 2 region. The researcher carried out his study at these 
two facilities to compare how antiretroviral treatment is administered in rural and urban 
settings and to gain a more holistic understanding of the problem of HIV/AIDS in the 
regions exhibiting the highest HIV prevalence.  
 In the past many HIV/AIDS strategies addressed either prevention or treatment 
of this epidemic, but recent data suggests that comprehensive care in which treatment and 
prevention work together provides the best strategy for decreasing the presence of 
HIV/AIDS in Uganda (see Appendix B).7 According to Uganda’s progress report “The 
epidemic is still predominantly heterosexually transmitted with 80% of infections 
attributable to heterosexual transmission. Mother to child transmission accounts for 20% 
while blood borne and other infections account for less than 1%.8” Despite these figures, 
most research focuses on PMTCT but men bear just as much responsibility as women in 
this battle against HIV/AIDS. In Uganda, men often engage in polygamous practices 
more than women and engage in more risky lifestyle habits. While many argue that these 
factors play no significant role in HIV transmission, research on this matter indicates, 
“Sharp increases in monogamy also contributed to lowering the risk for HIV infection or 
                                                
6 UAIS (2011). 2011 Uganda AIDS Indicator Survey. Retrieved from 
http://health.go.ug/docs/UAIS_2011_FACT_SHEET.pdf 
7 Salomon, J. A., Hogan, D. R., Stover, J., Stanecki, K. A., Walker, N., Ghys, P. D., & 
Schwartländer, B. (2005). Integrating HIV prevention and treatment: from slogans to 
impact. PLoS Medicine, 2(1), e16. 
8 UNAIDS. (2013). Global AIDS Response Progress Report: Uganda Jan 2010-Dec 2012. 
Retrieved from 
http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012co
untries/ce_UG_Narrative_Report[1].pdf 
 
 
10 
the periods 1989-1995 and 1995-2000. These increases reduced the risk for HIV infection 
among younger married and among unmarried sexually active women at all ages.9” These 
polygamous relationships can lead to a network of transmission between multiple women 
and children and ultimately, the risky lifestyles of men result in the transmission of HIV 
to all groups whether they are deemed vulnerable or not. Men’s role in the transmission 
of HIV/AIDS is often ignored but to eradicate this condition, their presence must be 
addressed more thoroughly. Lack of attention towards men in HIV/AIDS care strategies 
has left a significant impact on many of the other methods of comprehensive care, 
especially antiretroviral treatment.  
 
Antiretroviral Treatment 
 Antiretroviral treatment generally helps those individuals infected with HIV to 
live a healthy life but research indicates that men are more likely to die upon initiating 
antiretroviral treatment than women. Much of the HIV/AIDS research in Uganda focuses 
on women and children because they are generally viewed as vulnerable groups but the 
role of men in the prevalence and transmission of HIV/AIDS often receives less attention. 
Yet, approximately 530,000 men above the age of 15 currently live with HIV in Uganda 
suggesting that men do play a significant role in the spread and transmission of 
HIV/AIDS and focusing on men is critical to aiding in the fight against HIV/AIDS in this 
country. The impact of this lack of attention directed towards men in the fight against 
HIV/AIDS in Uganda will be investigated through the following literature survey. It is 
hypothesized that lack of focus on men results in a higher mortality rate for men 
beginning antiretroviral treatment than women because they generally start treatment at 
lower CD4-cell counts. Research has suggested that lack of attention towards men in the 
fight against HIV/AIDS creates fewer opportunities for men to receive provider-initiated 
HIV testing while women go through provider-initiated testing at early signs of 
pregnancy and in the midst of antenatal care. The following articles demonstrate and 
support this hypothesis as background for this study, which aims to determine whether 
                                                
9 Singh, S., Darroch, J. E., & Bankole, A. (2004). A, B and C in Uganda: The roles of 
abstinence, monogamy and condom use in HIV decline. Reproductive Health 
Matters, 12(23), 129-135. 
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lack of opportunity for provider-initiated HIV testing for men in Uganda contributes to 
the disparity in mortality rate between men and women initiating antiretroviral treatment 
and to propose methods to incorporate more provider-initiated HIV testing for men into 
Uganda’s healthcare system.  
 In “The first decade of antiretroviral therapy in Africa,” Ford et. al discuss the 
global effort to decrease the cost accessibility of antiretroviral therapy in developing 
countries. Initially, efforts to invest in antiretroviral treatment were not viewed as cost-
effective because the cost was unaffordable for the average individual in a developing 
country as well as the fact that prevention was viewed as a superior form of combating 
HIV/AIDS than treatment. Experts from all over the world urged that those living with 
HIV should be able to live a healthy life rather than a race to their death. Global effort 
effectively lowered the cost of this treatment allowing individuals in developing countries 
in Africa to gain access. The article urges that starting treatment earlier results in greater 
survival among patients and that greater antiretroviral treatment coverage can help 
decrease transmission of HIV. The authors insist “efforts are needed to reinforce the 
treatment cascade all along the pathway from HIV testing to early initiation to lifelong 
adherence to treatment10”. This article highlights the importance of antiretroviral 
treatment and urges that early adherence to the treatment is essential to survival. 
Therefore, this article justifies the focus on antiretroviral treatment for this study and 
provides background to the hypothesis that men start antiretroviral treatment later than 
women, leading to a higher mortality rate for men upon initiating this treatment.  
 In “Expanding HIV care in Africa: making men matter,” the authors discuss all 
the efforts made to provide women with HIV treatment before stating that far more 
women than men receive antiretroviral treatment. The article states “men appear to enter 
cARTprogrammes at a more advanced clinical stage and, as a consequence, mortality 
rates are higher in men11”. The article also urges “in many countries antenatal care 
services provide an important entry point to HIV/AIDS testing and treating, which 
                                                
10 Ford, N., Calmy, A., & Mills, E. J. (2011). The first decade of antiretroviral therapy in 
Africa. Global Health, 7(1), 33-33. 
 
11 Mills, E. J., Ford, N., & Mugyenyi, P. (2009). Expanding HIV care in Africa: making 
men matter. The Lancet, 374(9686), 275-276. 
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creates a particular opportunity for women to access care. Similar access points do not 
exist for men, although circumcision programmes, if expanded, would provide such an 
opportunity in the future8”. This article supports the hypothesis that men do have a higher 
mortality rate upon initiation of treatment because of a lack of opportunity for provider-
initiated testing. The article also suggests circumcision programs as potential methods of 
implementing this level of HIV testing for men, which will be expanded upon further in 
this project.  
 In “Male gender predicts mortality in a large cohort of patients receiving 
antiretroviral therapy in Uganda,” the authors specify that the findings of the previous 
article are relevant to the country of Uganda. They state that men in Uganda have less 
access to HIV/AIDS care than women, creating a higher mortality rate for men beginning 
antiretroviral treatment. Finally, the article urges that gender sensitive antiretroviral 
treatment would maximize the benefits of this treatment for the country of Uganda12. 
Also, in “Increased mortality among HIV-positive men on antiretroviral therapy: survival 
differences between sexes explained by late initiation in Uganda” the authors provide 
statistical analysis that prove the disparity in mortality rate between genders is caused by 
late initiation of treatment as a result of a lack of access to HIV/AIDS care and provider-
initiated testing. These articles support the hypothesis that incorporating more provider-
initiated testing for men in the healthcare system would lead to greater efficiency of 
antiretroviral treatment in Uganda13. The following section will highlight past efforts to 
incorporate circumcision programs into comprehensive HIV/AIDS care strategies to gain 
an understanding of their effectiveness in providing the citizens of Uganda with universal 
access to all forms of HIV/AIDS care and support. 
 
                                                
12 Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Hogg, R. S., Ford, N., ... & Cooper, C. 
L. (2011). Male gender predicts mortality in a large cohort of patients receiving 
antiretroviral therapy in Uganda. Journal of the International AIDS Society, 14(1), 52. 
13 Kanters, S., Nansubuga, M., Mwehire, D., Odiit, M., Kasirye, M., Musoke, W., ... & 
Mills, E. J. (2013). Increased mortality among HIV-positive men on antiretroviral 
therapy: survival differences between sexes explained by late initiation in 
Uganda. HIV/AIDS (Auckland, NZ), 5, 111. 
13 
 Male Circumcision Programs 
 Male circumcision programs have the potential to significantly reduce the 
prevalence of HIV/AIDS in Uganda in multiple ways. First of all, the act of circumcision 
for men significantly reduces the risk of contracting HIV from penile-vaginal sex.14 
Based on this information, many organizations have initiated a “safe male circumcision” 
campaign across the country in an effort to “contribute to the reduction in HIV and other 
Sexually Transmitted Infections incidences through increased safe male circumcision 
uptake.15” The majority of the population of Uganda remains uncircumcised so proper 
implementation of this program can make an impact on the prevalence of HIV/AIDS in 
Uganda. Despite the potential of this program to affect the health and well being of the 
citizens of Uganda, news sources state, “The UAC acknowledges that, since the 
programme's launch in 2010, it has not been formally scaled-up nationally, and effective 
linkages between SMC and other HIV services have not been put in place.16”  Lack of 
funding and coordination from the Ugandan Government effectively limits the potential 
of these programs and campaigns.  
 These programs not only can reduce the risk of HIV transmission during sex but 
also can create an avenue for men to engage in more provider-initiated testing and 
treatment for HIV/AIDS. Many hospitals and facilities have used antenatal clinics as 
effective methods of provider-initiated HIV/AIDS testing and care for women and these 
circumcision programs can be used as similar ways of engaging men in provider-initiated 
testing as well. This study seeks to further evaluate the effectiveness of these programs in 
engaging more men in provider-initiated treatment. Male engagement in comprehensive 
                                                
14 Centers for Disease Control and Prevention. (2013, April 15). Male Circumcision. 
Retrieved from http://www.cdc.gov/hiv/prevention/research/malecircumcision/ 
15 National Communication Strategy. (2010). Safe Male Circumcision for HIV 
Prevention. 1-34. 
16 IRIN news (2012 November 6). UGANDA: Mixed progress in male circumcision 
campaign from http://www.irinnews.org/report/96725/uganda-mixed-progress-in-male-
circumcision-campaign 
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HIV/AIDS care strategies could potentially decrease the gender disparities in access to all 
forms of HIV/AIDS care and support. Universal access to treatment and support is 
possible but proper implementation and support by the Ugandan Government is critical in 
this idea becoming reality.  
 
Justification 
 
Efforts to eradicate HIV/AIDS from the country of Uganda have been very 
effective, but studies show that a lack of attention towards the treatment of HIV/AIDS for 
men has reduced the effectiveness of treatment and prevention for the country of Uganda. 
This study focuses on men in an attempt to reduce and eliminate the disparity in mortality 
rate between men and women initiating antiretroviral treatment, thus increasing the 
effectiveness of antiretroviral treatment within the entire country. This study also plans 
on comparing HIV/AIDS efforts of hospitals in urban and rural settings to gain a holistic 
perspective on HIV/AIDS treatment and prevention strategies in Uganda. Providing men 
with more provider-initiated testing has been hypothesized to reduce this disparity and 
this study aims to test this hypothesis and propose methods in which HIV testing may 
become more common for men. Focusing on men in the fight against HIV/AIDS is a 
critical step in eliminating the prevalence of the human immunodeficiency virus within 
the entire population and this study aims to provide that focus.  
 
Statement of Objectives 
The objectives of this study include: 
1. To assess if there are gender differences in access to HIV testing and 
antiretroviral treatment services  
2. To further examine the causes of disparities between men and women in access to 
HIV prevention and treatment  
3. To establish the differences in mortality rate between men and women upon their 
initiation of antiretroviral treatment 
15 
4. To compare HIV treatment, counseling, and antiretroviral treatment services for 
men in urban and rural facilities in Uganda  
5. To propose methods to increase opportunities for men to engage in provider-
initiated HIV testing. 
 
This study will be driven by two hypotheses;  
1. Men have a higher mortality rate than women upon initiating antiretroviral 
treatment. 
2. Men initiate antiretroviral treatment at later stages of HIV infection than women.  
 
Methodology 
 
Overview 
This study was conducted from October 24, 2013 until December 1, 2013 over a 
six-week practicum period. The researcher spent the first three weeks at TASO Mulago 
while spending the remaining three weeks in St. Francis Naggalama Hospital in Mukono 
District to compare how comprehensive HIV/AIDS care is administered and received in 
an urban setting and a rural setting. The researcher used observation, interview, focus 
group discussions, and statistical analysis to gather qualitative and quantitative data.  
 
Study Population and Sampling 
 For qualitative analysis, the researcher interviewed 52 men and 76 women at 
TASO Mulago in the form of focus group discussions. The researcher received 
participants randomly from client liaisons, former clients of TASO who have seen vast 
improvement in their lives as a result of antiretroviral therapy. These liaisons were 
instructed to provide the researcher with gender-exclusive and gender-mixed groups of 
individuals age 18 or older who currently engage in antiretroviral therapy. At St. Francis 
Naggalama Hospital the researcher interviewed 19 men and 23 women using focus group 
discussions. The Director of Data Collection at St. Francis Naggalama Hospital chose 
16 
these groups randomly under the same inclusion and exclusion principles stated earlier. 
The researcher accumulated participants until the data collected reached a saturation 
point in which no new answers were recorded. 
For quantitative analysis, the researcher used the electronic records at TASO 
Mulago to accumulate participants who have started antiretroviral therapy from January 
2011 to June 2013. To establish the mortality rate at TASO Mulago, the researcher 
accumulated data from all 43,158 clients initiating ART at TASO since their 
implementation of ART into their HIV/AIDS care strategy. The researcher used existing 
data sets to augment this study. These dates were chosen to represent the population of 
TASO clients that recently initiated antiretroviral treatment to create a sample size of 903 
men and 2,355 women. When analyzing CD4 cell count, the researcher filtered out all 
clients who did not possess a value for CD4 cell count within 6 months before initiation 
of ART, leaving the sample size for CD4 cell count analysis at 384 men and 960 women. 
St. Francis Naggalama Hospital did not possess any electronic record system and as a 
result of time constraints, the researcher could not accumulate data from every client 
initiating antiretroviral treatment from January 2011 to June 2013. As a result the 
researcher used Farum’s 1997 formula of calculating sample size, which states that 
Sample size= N/ (1 +Ne2) 
Where N is the accessible population 
And e is the level of significance (0.05) 
The Director of Data Collection at St. Francis Naggalama Hospital estimated that 600 
clients 18 years and older have initiated antiretroviral therapy between the dates of 
January 2011 to June 2013. Using this number as the accessible population, the 
researcher randomly sampled participants from patient files in the hospital’s data room to 
reach a sample size of 240 participants.  
 
Inclusion 
The participants included in this study must be 18 years or older and must have 
initiated antiretroviral treatment.  
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Exclusion 
Participants under the age of 18 as well as participants who have not initiated 
antiretroviral treatment were excluded from this study.  
 
Variables 
 In focus group discussions, the researcher explored variables including 
occupation, gender, marriage status, motivations for HIV testing, perceptions of HIV 
testing, perceptions of antiretroviral therapy, challenges of engaging in antiretroviral 
therapy, and perceptions of male circumcision to gain a greater understanding of cultural 
and social factors responsible for men’s lack of engagement in comprehensive HIV/AIDS 
care. The interview schedule used in these focus group discussions has been appended 
here in Appendix C (See Appendix C).  In semi-structured interviews with various 
healthcare professionals, the researcher sought to gain a better understanding of gender 
differences in reception of sensitization strategies, perceived effectiveness of 
antiretroviral therapy as a treatment strategy, and perceived impact of circumcision 
programs as methods of increasing male engagement in provider-initiated HIV testing. 
Variables measured in quantitative analysis include gender, age at initiation of 
antiretroviral therapy, CD4 cell count at initiation of antiretroviral therapy, WHO disease 
stage at initiation of antiretroviral therapy, and mortality after initiation of antiretroviral 
therapy. These variables were measured to test the hypothesis that men have a higher 
mortality rate upon initiation of antiretroviral treatment as a result of delayed access to 
comprehensive HIV/AIDS care and provider-initiated testing and counseling. CD4 cell 
count represents the strength of the immune system and typically ranges from 500-1000 
cells/mm.3 A client with a CD4 cell count value of less than 350 cells/mm3 should begin 
18 
antiretroviral treatment.17 WHO disease stage numbers range from 1 to 4. Full 
descriptions of each clinical stage can be found in the appendix (See Appendix D)18.  
 
Procedure 
 The methods of focus group discussion, formal and informal interviews, 
observation and statistical analysis will be expanded upon and discussed in the following 
sections.  
 
Observation 
The researcher used observation to better understand and compare how TASO 
Mulago and St. Francis Naggalama Hospital each administered HIV/AIDS care and 
support based on setting and location. The researcher used this method of data collection 
to set a critical foundation for the facilitation and operation of other data collection 
methods. Observation strengthened the questionnaires and interview schedules used to 
acquire data in focus group discussions and formal and informal interviews. These other 
methods of data collection supplemented various observations noted by the researcher. 
Observation included noting clinic days, observing the ratio of male to female patients 
receiving antiretroviral therapy, examining the processes that clients experienced to 
receive treatment, and identifying the procedure that each facility followed in their 
administration of HIV/AIDS care. Through observation the researcher was able to 
properly implement the following data collection methods to gain a holistic 
understanding of antiretroviral treatment administration and reception in a rural and 
urban setting.  
 
                                                
17 AIDS.gov. (2010 October 11). CD4 Count. Retrieved from http://www.aids.gov/hiv-
aids-basics/just-diagnosed-with-hiv-aids/understand-your-test-results/cd4-count/ 
18 World Health Organization. (2005 February).  INTERIM WHO CLINICAL STAGING 
OF HIV/AIDS AND HIV/AIDS CASE DEFINITIONS FOR SURVEILLANCE. 
Retrieved from http://www.who.int/hiv/pub/guidelines/clinicalstaging.pdf 
 
19 
Focus Group Discussions 
 In the interest of time, the researcher used focus group discussions in groups of 5-
7 participants to reach a substantial number of participants initiating antiretroviral 
treatment ages 18 and older. The groups were mostly a mixture of men and women but 
groups of all men and all women were included to eliminate group dynamics as a variable 
for how responses were given. A standard interview schedule was used to better compare 
the answers provided by each focus group. The researcher hired an interpreter at each 
facility to eliminate the language barrier between the researcher and the participants. The 
interpreter at TASO Mulago was chosen by the facility to help provide an interpreter that 
had significant knowledge of the problem of HIV/AIDS in Uganda. The Director of Data 
Collection at St. Francis Naggalama Hospital served as the interpreter for focus group 
discussions facilitated at Naggalama. The researcher recorded every focus group 
discussion with an electronic recording device and transcribed the responses later while 
the interpreter asked the questions provided by the researcher in the local language. Every 
discussion began with a general introduction to the purpose of the study and all 
participants were informed that all answers were anonymous and not mandatory.  
 
Formal and Informal Interviews 
 The researcher conducted interviews with selected healthcare professionals to 
gain as much knowledge from each individual as possible. Interviews were semi-
structured in which the majority of questions previously prepared and some questions 
were created on the spot as a result of certain responses. Interview schedules for each of 
these interviews can be found in the appendix (see appendix E). Participants were chosen 
to represent all aspects of comprehensive HIV/AIDS care including antiretroviral 
medication and therapy, counseling, community sensitization, and circumcision 
programs. An interview with an HIV/AIDS counselor at TASO Mulago on November 7, 
2013 helped the researcher contextualize community sensitization and counseling 
services while analyzing the effectiveness of these strategies on each gender. On 
November 8, 2013 Dr. Simon Sentumbwe, a physician and researcher of HIV/AIDS in 
Uganda provided great insight to issues concerning research and administration of 
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comprehensive HIV/AIDS care strategies as well as engaging men in circumcision 
programs. Also on November 8, 2013 a nurse at the safe male circumcision clinic 
sponsored by Makerere University in Kampala, Uganda was interviewed to provide 
insight to the manner in which the clinic recruits clients as well as how the clinic 
operates. Finally, a pharmacist at St. Francis Naggalama Hospital was interviewed on 
November 19, 2013 to gain a better perspective of the efficiency and effectiveness of 
antiretroviral medication. These interviews were supplemented with various informal 
interviews throughout the duration of the study.  Overall, these interviews augmented and 
validated the information received from participants in focus group discussions and 
provided a better understanding of all facets of comprehensive HIV/AIDS care strategies. 
 
Statistical Analysis Using ANOVA Chi-Squared Test 
For the quantitative aspect of this study, the researcher used Analysis of Variance 
(ANOVA) to test the hypothesis that the higher mortality rate exhibited by men at their 
initiation of antiretroviral treatment is attributed to later initiation measured by initial 
CD4 cell count and initial WHO disease stage. Analysis of variance was used to quantify 
the statistical significance that gender had on CD4 cell count (measured in cells/mm3) at 
initiation of antiretroviral treatment. The analysis used the mean values of CD4 cell 
counts for men and women at ART initiation. Data recorded from patient files are 
accurate within six months of initiating ART. P values less than 0.05 were considered 
significant. All data was collected from the electronic databases of TASO Mulago and 
from patient files from St. Francis Naggalama Hospital. All analysis was conducted using 
STATA, a data analysis and statistical software. The mortality rate of those individuals 
aged 18 or older who have initiated ART anytime within January 2011 to June 2013 was 
calculated using the following formula. 𝑅 = 𝑥𝑡 10! 
Where R is the Mortality Rate 
x is number of dead clients 
t is the total population sampled 
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These dates were chosen to represent those recently initiating treatment while 
allowing for 6 months of progression on the treatment regime. The rate estimates the 
number of clients dead per 1000 clients. At St. Francis Naggalama Hospital, mortality 
was not recorded in patient files. Therefore, the researcher deemed those patients who 
have not returned to the facility within six months of their follow-up date as lost to follow 
up. The researcher also inferred that 30% of patients lost to follow up were dead, 
following the procedure of other studies conducted within the same subject matter in 
Uganda.19   
 Finally, the researcher used a Chi-Squared Test to establish the statistical 
significance of these established mortality rates and to identify the statistical significance 
of collected WHO disease stage numbers at ART initiation. The Chi-Squared test was 
used based on the null hypothesis that men and women should have the same mortality 
rate upon initiation of ART. This test provides a probability that a difference in mortality 
rate is statistically significant or due to chance. P-values smaller than 0.05 were 
considered significant. The Chi-squared test was also used to test the null hypothesis that 
men and women should initiate ART at the same WHO disease stages. The probability 
value resulting from this test will determine whether differences in WHO disease stages 
numbers between men and women initiating ART were due to chance or statistically 
significant. P-values smaller than 0.05 were considered significant.  
 
Challenges and Biases 
 Each method the researcher used played a great role in the accumulation of data 
necessary for this project but all data collection methods provide challenges and biases. 
Observations can incorporate a researcher’s personal biases into the data collected and as 
a result the researcher attempted to supplement all data collected from observations with 
formal and informal interviews and focus group discussions.  
                                                
19 Mills, E. J., Bakanda, C., Birungi, J., Chan, K., Ford, N., Cooper, C. L., ... & Hogg, R. 
S. (2011). Life expectancy of persons receiving combination antiretroviral therapy in 
low-income countries: a cohort analysis from Uganda.Annals of internal 
medicine, 155(4), 209-216. 
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The researcher selected interpreters with a vast knowledge of the subject matter 
and sometimes interpreters would analyze information rather than translate it, resulting in 
concise, summarized responses rather than full responses. This may have resulted in 
personal bias in some of the responses recorded from the focus group discussions as well 
as some missing information. Use of interpreters also forces the researcher to rely on the 
interpreters providing correct responses to ensure valid collected data.  
 Mortality is rarely recorded at TASO Mulago because client contacts may not 
communicate the death of a client to the facility that was providing the client treatment. 
Therefore the electronic records from TASO Mulago may not represent every individual 
who has died after initiating ART but this outside factor should affect men and women 
clients equally. Therefore, the data collected by the researcher equally represents the men 
and women who are clients at TASO Mulago and St. Francis Naggalama Hospital. Also, 
substantial differences in sample size may distort the researcher’s ability to compare 
statistics at each facility. The researcher relied on Farum’s 1997 formula to provide 
justification for proper representation of clients recently initiating ART at St. Francis 
Naggalama Hospital to allow proper comparison to statistics from TASO Mulago. 
 
Statement of Ethics 
 The researcher of this study conducted all research in an ethical manner. 
Permission to conduct this preliminary study was provided by TASO Mulago and St. 
Francis Naggalama Hospital and the investigator adhered to all the ethical conduct 
required in this exercise.  More specifically, all respondents shall remain anonymous and 
the researcher shall not publish any responses to survey, focus groups, or interviews 
without written consent from TASO, St. Francis Naggalama Hospital, or the respondents. 
The results gathered from this study are presented as accurately as possible without bias 
or manipulation. Most of all, the researcher attempted to respect and honor the rules and 
philosophies of the facilities used as well as respect and honor the participants of this 
study. Follow up permission has been granted by the Uganda National Council for 
Science and Technology body through the School for International Training Research 
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Model 3. Consent forms used during the key informant interviews have been appended 
under Appendix F (see Appendix F). 
 
Results  
Mortality 
 The researcher sought to test two hypotheses with this study. The researcher 
established the mortality rate for men and women at TASO Mulago and St. Francis 
Naggalama Hospital to test the hypothesis that men exhibit a higher mortality rate than 
women upon initiation of antiretroviral treatment. Furthermore, the researcher used 
statistical analysis to test the hypothesis that this higher mortality rate can be attributed to 
delayed access to provider-initiated HIV/AIDS care for men. Using baseline CD4 cell 
counts, baseline WHO disease stage numbers, and measuring all-cause mortality, the 
researcher conducted the same analysis at each facility as a means of greater 
representation for the Central 1 and Central 2 regions of Uganda, the regions with the 
highest prevalence of HIV/AIDS, while comparing urban and rural facilities.   
  Based on all 43,158 clients initiating ART at TASO Mulago (14,316 men and 
28,842 women) 236 men and 321 women were recorded as dead resulting in a mortality 
rate of 16.485 deaths per 1000 male clients and 11.130 deaths per 1000 female clients. 
These results suggest that men have a higher mortality rate than women upon initiation of 
antiretroviral treatment at TASO Mulago. The following table highlights this data.  
 
Table 1. Mortality Rate of Male and Female Patients at TASO Mulago20 
	  	   Male	   %	   Female	   %	  
Dead	   236	   1.65	   321	   1.11	  
Total	   14316	   	   28842	   	  	  
Mortality	  Rate	   16.485	   	  	   11.13	   	  	  
 
                                                
20 Data collected by the researcher from electronic records at TASO Mulago 
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At St. Francis Naggalama Hospital, the researcher analyzed 240 clients (72 men 
and 168 women) for mortality but mortality was not recorded in patient records. As a 
result, the researcher tracked those patients lost to follow up and assumed 30% of patients 
lost to follow up had died. 13 women and 18 men were lost to follow up, resulting in an 
estimation that 4 women and 5 men had died since their initiation of ART. Using the 
same protocol, the researcher established that the mortality rate for men is approximately 
69.444 deaths per 1000 clients initiating ART at St. Francis Naggalama Hospital and for 
women the rate is approximately 23.809 deaths per 1000 clients initiating ART at this 
hospital. This is highlighted in the following table. 
 
Table 2. Mortality Rate of Male and Female Patients at St. Francis Naggalama Hospital21 
	   Male	   %	   Female	   %	  
Dead	  	   5	   6.94	   4	   2.38	  
Total	   72	   	   168	   	  
Mortality	  Rate	   69.444	   	   23.809	   	  
	   	   	   	   	   
To establish the statistical significance of these mortality rate values, the 
researcher utilized a chi-squared test to determine the probability that men’s higher 
mortality rate was based on chance. According to the null hypothesis, men should have 
the same mortality rate as women at both facilities. Therefore men should have a 
mortality rate of 11.130 deaths per 1000 clients, the same rate as women at TASO 
Mulago and 23.809 deaths per 1000 clients, the same rate as women at St. Francis 
Naggalama Hospital. Based on this null hypothesis, approximately 159 men should have 
died rather than 236 at TASO Mulago and approximately 2 men should have died rather 
than 5 at St. Francis Naggalama Hospital. Considering data with a p-value less than 0.05 
as statistically significant, the test resulted in p-values less than 0.0001 and 0.01 at TASO 
Mulago and St. Francis Naggalama Hospital respectively. Therefore, these values were 
compared to find that men’s observed mortality rate is significantly higher than that for 
women at both facilities. The results from both facilities have been summarized in the 
following table. The causes for this significant difference will be explored in detail in the 
following section. 
                                                
21 Data collected by the researcher from patient files at St. Francis Naggalama Hospital 
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Table 3. Results of Chi-Squared Test of Mortality Rate22  
Sample	   Variable	   Observed	  #	   Expected	  #	   Chi-­‐Squared	  
Value	  
dF	   p-­‐value	  
TASO	  
Mulago	  
Dead	   236	   158.9076	   37.82	   1	   p<0.0001	  
	   Alive	   14080	   14157.0924	   	   	   	  
St.	  Francis	  
Naggalama	  
Dead	  	   5	   1.7136	   6.456	   1	   p=<0.0111	  
	   Alive	   67	   70.2864	   	   	   	  
 
 
Differences in Mortality Explained by Late Initiation 
The researcher tested the second hypothesis that men’s higher mortality rate upon 
initiation of ART is a result of a later initiation by gathering CD4 cell counts and WHO 
disease stage numbers from clients at TASO Mulago and St. Francis Naggalama Hospital 
at their initiation of ART. These values represent the condition of the client at their ART 
initiation and their timing of care. A lower CD4 cell count and a higher disease stage 
number are both characteristics of later initiation and greater prevalence of the human 
immunodeficiency virus within the human body.  
At TASO Mulago 1,344 people possessed a baseline CD4 cell-count upon 
initiation of ART between January 2011 and June 2013 (384 men and 960 women). The 
average CD4 cell count for men at this facility was 250.3 cells/mm3 and the average for 
women was 317.6 cells/mm3. Using one-factor ANOVA to analyze the statistical 
significance of this difference, the researcher found a p-value less than 0.0001, proving 
that at TASO Mulago men begin ART with a significantly lower CD4 cell count 
representing later initiation. The results have been summarized in the following table. 
 
                                                
22 Based on data collected by the researcher from electronic records at TASO Mulago and 
patient files at St. Francis Naggalama Hospital 
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Table 4. ANOVA results for CD4 cell count at ART initiation from TASO Mulago23 
	  	   N	   Mean	   Std.	  
Deviation	  
Std.	  Error	   Minimum	   Maximum	  
Female	   960	   317.5958	   195.7538	   6.317926	   0	   1180	  
Male	   384	   250.2708	   157.4733	   8.036024	   2	   1222	  
Total	   1344	   298.3601	   188.0441	   5.129323	   0	   1222	  
ANOVA	  
	   Sum	  of	  Squares	   df	   Mean	  Square	   F	   	  p-­‐value	  Between	  
Groups	   1243243	   1	   1243243	   36.07731	   P<0.001	  
Within	  Groups	   46246009	   1342	   34460.51	   	   	  
Total	   47489252	   1343	   	  	   	  	   	  	  
 
At St. Francis Naggalama Hospital the researcher followed the same protocol with 
a sample size of 240 clients (72 men and 168 women). The average CD4 cell count for 
men was 157.89 cells/mm3 and the average CD4 cell count for women was 214.29 
cells/mm.3 Results from the one-factor ANOVA revealed a p-value of 0.0019, proving 
that at St. Francis Naggalama Hospital men also initiate ART at significantly lower CD4 
cell counts. Thus, late initiation based on CD4 cell counts is a common factor at both 
facilities. The results have been summarized in the following table. 
Table 5. ANOVA results for CD4 cell count at ART initiation from St. Francis 
Naggalama Hospital24 
	   N	   Mean	   Std.	  Deviation	   Std.	  Error	   Minimum	  	   Maximum	  
Female	   168	   214.2917	   131.0907	   10.1139	   0	   827	  
Male	   72	   157.8889	   117.4554	   13.8422	   3	   643	  
Total	   240	   197.3708	   129.5258	   8.3609	   0	   827	  
	   	   ANOVA	   	   	   	  
                                                
23 Based on data collected by the researcher from electronic records at TASO Mulago 
 
24 Based on data collected by the researcher from patient files at St. Francis Naggalama 
Hospital 
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   Sum	  of	  
Squares	  
df	   Mean	  
Square	  
F	   p-­‐value	  
Between	  Groups	   160336.1764	   1	   160336.1764	   9.91	   0.001854	  
Within	  Groups	   3849353.819	   238	   16173.7555	   	   	  
Total	   4009689.996	   239	   	   	   	  
 
Using WHO disease stage as another indicator of late initiation, the researcher 
found that at TASO Mulago, 7.5 percent of male clients initiated ART at WHO stage 3 
and 1.6 percent of men initiated ART at stage 4. At the same facility, 4.6 percent of 
women initiated ART at stage 3 and 0.9 percent of women initiated ART at stage 4. At 
St. Francis Naggalama Hospital, the researcher found that 22.2 percent of men initiated 
ART at stage 3 and 11.1 percent of men initiated ART at stage 4. At the same hospital, 
11.3 percent of women initiated ART at stage 3 and 2.4 percent of women initiated ART 
at stage 4. The following tables highlight this data.25 
Table 6. WHO disease stage numbers of clients at TASO Mulago at ART Initiation 
Gender	   Female	   	  	   Male	   	  	   Total	   	  	  
	  	   N	   %	   N	   %	   N	   %	  
Stage	  1	   23	   1.0	   11	   1.2	   34	   1.0	  
Stage	  2	   2,202	   93.5	   810	   89.7	   3,012	   92.4	  
Stage	  3	   109	   4.6	   68	   7.5	   177	   5.4	  
Stage	  4	   21	   0.9	   14	   1.6	   35	   1.1	  
Total	   2,355	   100	   903	   100	   3,258	   100	  
 
Table 7. WHO disease stage numbers of clients at St. Francis Naggalama Hospital at 
ART initiation26 
Gender	   Female	   	   Male	   	   Total	   	  
	   N	   %	   N	   %	   	   %	  
Stage	  1	   28	   16.667	   6	   8.333	   34	   14.167	  
Stage	  2	   117	   69.642	   42	   58.333	   159	   66.25	  
Stage	  3	   19	   11.31	   16	   22.222	   35	   14.583	  
Stage	  4	   4	   2.381	   8	   11.111	   12	   5	  
Total	   168	   100	   72	   100	   240	   100	  
 
                                                
25 Based on data collected by the researcher from electronic records at TASO Mulago 
26 Based on data collected by the researcher from patient files at St. Francis Naggalama 
Hospital 
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While these results indicate that men initiate ART at higher WHO disease stages 
than women at both facilities, the researcher utilized another chi-squared test to 
determine the statistical significance of these findings. Considering any data with a p-
value less than 0.05 as statistically significant, the researcher found probability values 
less than 0.0001 and less than 0.0001 at TASO Mulago and St. Francis Naggalama 
Hospital respectively, demonstrating that men initiate ART at significantly higher WHO 
disease stages than women at both facilities. The following tables illustrate these 
findings.  
Table 8. Results of Chi-squared test of WHO disease stages at TASO Mulago and 
St. Francis Naggalama Hospital.27 
Sample	   Variable	   Observed	  #	   Expected	  #	   Chi-­‐Squared	  
Value	  
dF	   p-­‐value	  
TASO	  Mulago	   Stage	  1	   11	   9.03	   22.926	   3	   p<0.0001	  
	   Stage	  2	   810	   844.305	   	   	   	  
	   Stage	  3	   68	   41.538	   	   	   	  
	   Stage	  4	   14	   8.127	   	   	   	  
St.	  Francis	  Naggalama	  	   Stage	  1	   6	   12.00024	   34.95	   3	   p<0.0001	  
	   Stage	  2	   42	   50.14224	   	   	   	  
	   Stage	  3	   16	   8.1432	   	   	   	  
	   Stage	  4	   8	   1.71432	   	   	   	  
 
 
Findings and Discussion 
After testing those hypotheses as a basis for the study, the researcher collected 
and analyzed qualitative data to determine the reasons for these significant differences in 
mortality rate, CD4 cell count, and WHO disease stage numbers between men and 
women in Uganda. The researcher analyzed differences in perceptions of HIV testing, 
antiretroviral treatment and circumcision programs as well as differences in opportunities 
for men and women to engage in provider-initiated HIV/AIDS care and support to 
understand why each facility had significantly more women than and to determine why 
men initiate ART later than women. The findings for these critical aspects of 
                                                
27 Based on data collected by the researcher from the electronic records at TASO Mulago 
and patient files at St. Francis Naggalama Hospital  
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comprehensive HIV/AIDS care will be explored in further detail in the following 
sections.  
Reasons and Motives for HIV Testing 
 The researcher found a significant difference in the reasons men and women seek 
HIV testing. Based on focus group discussions the majority of clients at TASO Mulago 
and St. Francis Naggalama Hospital test for HIV as a result of Routine Counseling and 
Testing (RCT). Most healthcare facilities highly encourage patients to test for HIV at the 
sign of illness to insure proper treatment for the ailment that they are diagnosing. Most 
clients that the researcher interviewed entered a healthcare facility to seek treatment for 
some illness and tested for HIV under this RCT method. The researcher found that 23 of 
the 50 men interviewed at TASO tested for HIV for this reason while 25 of the 67 women 
interviewed tested under this method. At St. Francis Naggalama Hospital 17 of 20 men 
interviewed used RCT as a testing method while 13 of the 20 women interviewed 
followed the same protocol. The difference in motivations for HIV testing resulted in a 
law insisting that women test for HIV during pregnancy. The researcher found that 14 of 
67 women at TASO Mulago tested for HIV as a result of this law while only 1 of 20 
women at St. Francis Naggalama Hospital tested under this same principle. Men do not 
have a similar avenue to test for HIV and, as a result, men are more likely to test for HIV 
once the harmful effects of the virus begin to show. This results in lower CD4 cell counts 
and higher WHO disease stages as noted earlier, resulting in a higher mortality rate for 
men as they initiate ART as well as a smaller number of men being engaged in 
HIV/AIDS care.  
This law also explains the larger number of women engaged in antiretroviral 
treatment services. To properly combat HIV prevalence, healthcare facilities must engage 
men in HIV/AIDS testing services before the virus begins to show symptoms. The 
Human Immunodeficiency Virus can remain in the human body for decades before 
symptoms begin to show.28 This high prevalence not only gives men in Uganda a large 
window of time to transmit the virus without any knowledge of its prevalence in their 
                                                
28 AIDS and HIV Infection. (n.d.). AIDS and HIV Infection. Retrieved December 1, 
2013, from 
http://www.healthcentral.com/encyclopedia/408/101.html?ic=506048#encyc_symptoms 
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body but also puts the health of hundreds of thousands of men in Uganda at risk. A 
proper HIV/AIDS care strategy must be able to limit this level of prevalence to protect 
the health and well being of the citizens of this country and an avenue for earlier HIV 
testing for men is the first step to accomplishing this task.  
 Community sensitization and counseling services could provide an avenue for 
men to engage in HIV/AIDS care at earlier stages of HIV infection. Clients in focus 
group discussions insisted that men are often too stubborn or too busy to test for HIV. 
According to a counselor at TASO, the notion of being sick makes men feel weak which 
is highly discouraged in Ugandan culture.29 Therefore, promoting HIV testing for men 
becomes a lot more difficult because of these cultural and social factors. The counselor 
insisted that skits and plays prove very effective in educating vulnerable groups about the 
dangers of HIV and the benefits of HIV testing. Effective sensitization can impact these 
social and cultural factors so that men feel encouraged to test though many men will 
discover their status and change no aspect of their lives out of fear of weakness. They do 
not inform their partners of their status, they hide the news from their families and 
friends, and they simply wait to die from the complications of AIDS. The counselor 
insisted that men often have a saying that “what I don’t know won’t hurt me but what I 
do know can hurt me.” The values in this saying drive a lot of the decisions that men in 
Uganda make about whether or not to test for HIV or if treatment is worthwhile. These 
social and cultural barriers to male engagement in HIV testing services suggest that while 
sensitization and counseling have provided great results in promoting effective HIV care, 
other avenues are necessary to promote more men to test for HIV services.  
 Many individuals in focus groups argued for mandatory HIV testing for all men 
but the counselor urged that this strategy would create more harm than good. She insisted 
that men should have the right to chose and forcing them to test for HIV will not 
effectively cross the social and cultural barriers to sensitization and counseling. Men 
must become interested and invested in their own health for true change to occur. Proper 
investment includes following treatment regimes, sharing knowledge of status with 
sexual partners, and eliminating transmission of the virus through safe sex and 
                                                
 
29 Interview Counselor at TASO, Kampala 7 November 2013 
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contraception. The counselor stated that forcing men to test only solves one part of a 
large puzzle, suggesting that knowing one’s status is not enough. Joining in the fight 
against the prevalence of transmission is everyone’s responsibility and this is only 
possible through constant engagement in comprehensive HIV/AIDS care strategies.  
 
Antiretroviral Treatment Services 
 Focus group discussions also provided the researcher with social and cultural 
factors affecting initiation and adherence to antiretroviral treatment. Many respondents in 
these focus groups stated that they were scared to take antiretroviral treatment because of 
various rumors suggesting that ARV’s were created to kill those living with HIV to 
eliminate the possibility of transmission. Stigma surrounding the use of antiretroviral 
medication and treatment creates another barrier to proper HIV/AIDS care. Without 
mandatory HIV testing for men, the critical step of persuading men to engage in 
HIV/AIDS care strategies with such rumors becomes extremely difficult. Sensitization 
and counseling services must prevent such rumors from spreading. Antiretroviral 
treatment has been an affordable and essential aspect of the battle against HIV/AIDS by 
promoting life in the midst of HIV infection and initiation of this treatment must not be 
hindered. This social factor also encourages the later initiation of men on antiretroviral 
treatment discussed earlier. Women must adhere to these medications during pregnancy 
but men can refuse to begin or adhere to these medications, especially those living with 
the belief that ART is designed to kill them. Proper education must be established to 
inform individuals holding this belief of the proper purpose and good intent of ART 
programs in Uganda.  
 Some respondents also suggested timing as a reason for lack of men testing for 
HIV and late initiation of antiretroviral treatment. Many clients at both TASO Mulago 
and St. Francis Naggalama Hospital spend the majority of their day waiting to receive 
medication and counseling services. An interview with Dr. Simon Sentumbwe revealed 
that many men have jobs in which they cannot leave for such a long time.30 He insisted 
that many men must rely on private facilities because government facilities are 
                                                
30 Interview Dr. Simon Sentumbwe, Kampala, Uganda 8 November 2013 
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overcrowded, resulting in a large waiting time. Dr. Sentumbwe encouraged more public 
private partnership (PPP) to allow for government-sponsored hospitals to limit waiting 
times while providing private facilities with more affordable medication, resulting in a 
larger audience. While the large time commitment necessary for proper health should be 
considered a sound investment, facilities can play a greater role in decreasing waiting 
times to promote greater interest and adherence to all forms of HIV/AIDS care, especially 
antiretroviral therapy.  
 Many respondents also indicated that poverty takes a huge toll on adherence to 
antiretroviral medication. According to Dr. Simon Sentumbwe, taking the medication 
requires a significant amount of water and the human body responds to the side effects of 
the medication better when the medicine is taken with a full meal. Antiretroviral 
treatment itself is affordable and even free at some institutions like TASO but proper 
adherence and avoidance of caustic side effects requires consistent access to food and 
water, which many clients simply do not possess. Respondents in focus groups have 
reported that this lack of access to food and water creates severe side effects such as 
hallucinations, skin rashes, and even temporary paralysis. While these side effects cause 
great trauma to an individual, they also create stigma around the use of antiretroviral 
medication, causing many people to believe in rumors such as the one stated in the 
previous paragraph. Once again, this finding discourages men from initiating and 
adhering to antiretroviral medication, leading to a higher mortality rate among men once 
they actually initiate ART. 
 Finally, the life-changing effects of antiretroviral medication can do more harm 
than good. Based on an interview with a pharmacist at St. Francis Naggalama Hospital, 
many individuals believe that ARVs have cured their HIV status even though it only 
addresses the symptoms.31 As a result they become sexually active and can potentially 
transmit the virus even though their harsh symptoms may disappear. Cultural norms 
permit men in particular to participate in polygamy so that this transmission can lead to a 
large number of partners becoming infected with the virus. Sensitization and education 
can each play a huge role in this aspect of HIV/AIDS care by informing people that 
transmission of HIV is still probable for individuals taking antiretroviral medication. As 
                                                
31 Interview Pharmacist, St. Francis Naggalama Hospital 19 November 2013 
33 
stated earlier, comprehensive HIV/AIDS care strategies create the best opportunity to 
combat HIV prevalence (See Appendix B). Thus, simply taking medication or testing for 
HIV are each critical preliminary steps to eliminating HIV from the country of Uganda 
but proper adherence to all aspects of comprehensive HIV/AIDS care including 
counseling, proper utilization of medication, sharing knowledge of one’s status and using 
contraception are all valuable and essential to combating HIV/AIDS prevalence. Forcing 
an individual to participate in one aspect of care will not prove effective. To fully 
eliminate gender disparities in access to comprehensive HIV/AIDS care requires that men 
fully engage in all aspects of HIV/AIDS care to join the fight to lower the prevalence of 
this virus from the country of Uganda. Based on these findings, the researcher proposes 
greater implementation of male circumcision programs to provide men in Uganda with 
the best opportunity to engage in comprehensive, provider-initiated HIV/AIDS care.  
 
Male Circumcision Programs as Avenues of Engagement 
 As stated earlier, implementation of circumcision programs would provide an 
avenue for men to test for HIV similar to the avenue women have through pregnancy and 
antenatal services. Based on focus group discussions, 35 of 50 men were not circumcised 
at TASO Mulago and 15 of 20 men at St. Francis Naggalama Hospital were not 
circumcised. Implementation of circumcision programs would benefit a large percentage 
of the population of men in Uganda by reducing their risk of contracting all STI’s and by 
engaging them in HIV care. Based on focus group discussions, social and cultural factors 
also create stigma on this issue. The Muslim faith encourages all individuals in their faith 
to circumcise at an early age but many men of other religions feel as if they should be 
excluded from this act if they are not Muslim. One respondent indicated that political 
leaders of Muslim faith have attempted to encourage safe male circumcision but they 
have met their fair share of opposition because of their faith. A large number of people 
felt that this was an attempt to convert the entire country to the Muslim faith rather than 
an attempt to expand the health benefits of male circumcision. Community sensitization 
must be implemented in these programs to combat stigma and encourage people of all 
faiths to engage in this aspect of HIV/AIDS care.  
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Circumcision programs are currently in place but they come with a fair share of 
flaws. Many respondents in focus group discussions stated that they feared circumcision 
because they only have access to government-sponsored hospitals in which patients only 
receive painkillers. Improper treatment of the wound resulting from circumcision surgery 
can result in severe complications that hinder a man’s ability to function in daily tasks. 
Some men have seen father figures and relatives die from the complications of 
circumcision because of a lack of proper treatment and, as a result, they refuse to become 
circumcised. Proper treatment comes from proper funding and lately donor and 
government funding has decreased for male circumcision programs according to Dr. 
Sentumbwe. Many outside benefactors understand the health benefits of the act of 
circumcision but using male circumcision programs as avenues for greater male access to 
comprehensive HIV/AIDS care services provides greater justification as to why these 
programs should be funded further.  
Makerere University initiated a safe male circumcision program that targets 
young men in an attempt to provide men with an accessible method of circumcision. 
Based on an interview with faculty at this circumcision facility, circumcisions are 
performed within an hour of patients arriving after a series of educational talks about the 
benefits of circumcision.32 Yet, this facility offers very little sensitization and treatment. 
Painkillers are administered after the surgery with instructions on how to handle the 
wound but based on focus group discussions these tactics still instill fear into a majority 
of men who are in need of the services.  
Through enhanced male circumcision programs men would receive sensitization 
about the problem of HIV/AIDS in Uganda as well as counseling on the proper steps to 
live functionally with the virus while taking the responsibility of aiding in the fight 
against HIV/AIDS prevalence. Education about antiretroviral treatment and its effects, 
proper contraception and abstinence, and disclosure to partners would all result from the 
act of circumcision, which already plays a role in decreasing HIV/AIDS transmission. 
Proper treatment must also be administered as well as referral to a facility with the 
resources necessary to provide all aspects of antiretroviral therapy services. Based on 
findings from this study, the majority of men living with HIV have not been circumcised, 
                                                
32 Interview Nurse, Safe Male Circumcision Clinic, Kampala, Uganda 8 November 2013 
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suggesting that a large number of men living with HIV in Uganda have not only refused 
to test for HIV based on the findings discussed earlier but also have not been 
circumcised. The potential audience for these programs is massive but proper funding 
must become a reality for proper implementation of these programs. Full engagement of 
men in comprehensive HIV/AIDS care can be achieved and an enhanced male 
circumcision program is the first step.  
 
Rural vs. Urban Comparison 
Throughout this practicum period, the researcher noticed some substantial 
differences in HIV/AIDS care in rural and urban areas.  First of all, the mortality rates 
established at St. Francis Naggalama Hospital are much higher for both genders than the 
mortality rates at TASO (69.4 deaths per 1000 men and 23.8 deaths per 1000 women at 
St. Francis Naggalama Hospital versus 16.5 deaths per 1000 men and 11.1 deaths per 
1000 women at TASO Mulago). Average CD4 values were also much lower at St. 
Francis Naggalama Hospital (157.9 cells/mm3 for men and 214.3 cells/mm3 for women 
versus 250.3 cells/mm3 for men and 317.6 cells/mm3 for women at TASO Mulago) while 
more clients exhibited a stage 3 or stage 4 WHO disease stage. Many individuals in rural 
areas do not have the same access to healthcare facilities and as a result they prolong 
initiation of ART even longer. Men in rural areas feel the effects of this fact most of all 
because they have multiple factors contributing to their late initiation, resulting in their 
substantially higher mortality rate (69.4 deaths per 1000 men). As a result men in rural 
areas were much more likely to test for HIV through the RCT method (17 out of 20 men). 
Men already have less access to comprehensive HIV/AIDS care and the rural setting 
further perpetuates this lack of access. Based on observations, the researcher found that 
many male clients at St. Francis Naggalama Hospital often missed appointments but 
followed up later at a random date to receive care. These delays signify the level of 
access these men have to access treatment. Their persistence to arrive at a later date 
suggests that they desire treatment and value their health but they often cannot engage at 
the proper timing. The researcher also noticed a substantial amount of men transferring to 
other facilities to increase access to HIV/AIDS services. This step plays a great role in 
efforts to engage men as well as in battling HIV prevalence all over the country. Greater 
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effort to involve men in HIV/AIDS care must be universalized for the entire country to 
access. A holistic approach is necessary to fully combat HIV/AIDS prevalence and 
universal access to these services involves those in urban and rural settings equally.   
 
Conclusions  
 
Based on the findings, the researcher has drawn conclusions based on the 
objectives of the study.  
 
Objective 1: To assess if there are gender differences in access to HIV testing and 
antiretroviral treatment services. 
 
  The researcher found numerous gender differences in HIV/AIDS care access. 
Results from the statistical analysis prove that men are more likely to die upon initiation 
of antiretroviral treatment. These results also indicate that men begin antiretroviral 
treatment at significantly lower CD4 cell counts and significantly higher WHO disease 
stage numbers, both of which emphasize later initiation of antiretroviral treatment. Using 
qualitative data to supplement these results, the researcher found differences in 
perception, adherence, and ultimately, opportunity to access comprehensive HIV/AIDS 
care, which will be explored in the next objective. 
 
Objective 2: To further examine the causes of disparities between men and women in 
access to HIV prevention and treatment  
 
Most participants interviewed in focus group discussions began HIV/AIDS care at 
the sign of symptoms of HIV infections, which can occur up to decades after initial HIV 
infection. Women often engaged in care as a result of pregnancy and without a similar 
avenue, the vast majority of men only accessed treatment and support as a result of grave 
illness. This finding explains the lower CD4 cell counts and higher WHO disease stages 
observed in the results section. Men require an avenue for provider-initiated HIV testing 
similar to women that informs them of their HIV status before symptoms begin to show.  
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Men struggle with stigma surrounding HIV testing and treatment services. Men 
view themselves as weak for testing for HIV or acknowledging their status. Therefore 
they often refuse to test or they never disclose their HIV status to their sexual partners. 
Other rumors also discourage men from seeking HIV/AIDS treatment such as the notion 
that ARVs were invented to kill all people with HIV to eliminate its transmission. 
Poverty also causes the harmful side effects of ARVs to plague those initially taking the 
medication. Other men see these side effects and, as a result, feed into the rumors and 
stigma surrounding this treatment.  
 
Objective 3: To establish the differences in mortality rate between men and women upon 
their initiation of antiretroviral treatment 
  
Electronic records at TASO Mulago and patient files from St. Francis Naggalama 
Hospital provided the researcher with the necessary data to establish the mortality rate of 
men and women at each facility. At TASO Mulago the mortality rate was 16.485 deaths 
per 1000 men and 11.13 deaths per 1000 women. At St. Francis Naggalama Hospital the 
mortality rate was 69.444 deaths per 1000 men and 23.809 deaths per 1000 women. 
Through this data, the researcher tested and proved the hypothesis that men initiate ART 
at higher mortality rates based on the facilities the researcher utilized.  
 
Objective 4: To compare HIV treatment, counseling, and antiretroviral treatment services 
for men in urban and rural facilities in Uganda. 
 
 Based on observations and statistical analysis, the researcher concluded that living 
in a rural area creates even less opportunities for men and women to engage in 
HIV/AIDS care. As established in the previous objective, the mortality rate for men and 
women was higher at St. Francis Naggalama Hospital than at TASO Mulago. Men in 
particular had a much higher mortality rate at 69.444 deaths per 1000 men. Expanding on 
this fact, the average CD4 cell count for men at St. Francis Naggalama (157.9 cells/mm3) 
was much lower than at TASO Mulago (250.3 cells/mm3). CD4 cell counts lower than 
350 cells/mm3 are considered significantly low, so the data from St. Francis Naggalama 
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is alarming. These men have very few opportunities to engage in HIV/AIDS care because 
they lack a proper avenue for provider-initiated HIV testing and they live in a rural area 
with lack of access to proper facilities for treatment. Many men often missed their formal 
appointment date to return on a different day, suggesting that men are interested in 
engaging in treatment and support but access is quite limited.  
Objective 5: To propose methods to increase opportunities for men to engage in provider-
initiated HIV testing. 
  
The researcher proposed that enhanced male circumcision programs provide the 
best method of increasing opportunity to engage in provider-initiated HIV testing. This 
method involves sensitization and education about HIV/AIDS prevalence and 
transmission, HIV testing, circumcision, and referral to a facility with proper resources 
for those infected with HIV. All of these aspects are critical to combating HIV/AIDS 
prevalence in Uganda and forcing men to engage in any one aspect alone will not 
empower them to want to make a difference in the prevalence of this epidemic. 
Encouragement and support through this avenue of provider-initiated testing are the best 
methods of engaging men more in the fight against HIV/AIDS.  
 
Recommendations 
 
Based on findings throughout this practicum period, the researcher proposes the 
following recommendations. Global efforts to eliminate PMTCT have been extremely 
effective but this effort needs to provide more focus on men living in Uganda with 
HIV/AIDS. As stated earlier, 80 percent of new cases of HIV result from heterosexual 
contact as opposed to PMTCT, which results in 20 percent of new cases. Both methods of 
transmission need to be addressed thoroughly but if the same level of attention posed 
toward PMTCT was directed towards men in the fight against HIV/AIDS prevalence and 
transmission then the great strides that have significantly reduced PMTCT can also 
significantly reduce heterosexual transmission.  
 While many individuals recommend mandatory HIV testing for men through 
various methods, the researcher recommends the opposite. Forcing men to engage in one 
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aspect of HIV/AIDS treatment will not effectively combat all of the social and cultural 
forces that stigmatize HIV testing and treatment. Forcing men to test will not encourage 
them to seek treatment or disclose their status to their sexual partners. Healthcare 
facilities must promote interest in the area of HIV/AIDS transmission and prevalence. 
Every citizen of Uganda can play a role in the battle against HIV/AIDS. Proper 
encouragement will lead to significant interest and, as a result, a large majority of 
Ugandan citizens can make great steps to ending this epidemic.  
 This global effort should place emphasis on Safe Male Circumcision Programs. 
Current programs do not have the resources to properly sensitize the community to 
combat the stigma surrounding HIV testing and male circumcision. These programs 
would provide a great avenue for men to engage in all facets of comprehensive 
HIV/AIDS care and support.  Proper funding and support for these programs would 
insure that men become educated about the problem of HIV/AIDS in Uganda and 
encourage that interest mentioned earlier. Yet, testing and circumcision represent the 
initial steps to proper implementation of these programs. Referrals should be made for 
clients based on location and facilities must continue to provide counseling and adequate 
treatment. The effectiveness of these programs relies on all of these aspects working 
efficiently and collectively to promote the reduction of HIV/ AIDS prevalence.  
Political leaders should continue to encourage the men of Uganda to engage in 
comprehensive HIV/AIDS care and support. This act should be highly celebrated as a 
strong, responsible action for all men to become involved in. Media also plays a great 
role in this step. Men should feel empowered through the act of circumcision and HIV 
testing rather than weak and vulnerable. Combating rumors and stigma is just as 
significant as combating HIV transmission and the individuals responsible for 
empowering the community can effectively decrease the power of stigma in relation to 
concerns of male engagement in HIV/AIDS care.  
Everyone feels the effects of HIV prevalence in Uganda and, as a result, everyone 
must play a role in eliminating this prevalence. Many individuals have lost their lives to 
complications from this virus and many people have lived in fear of exposing themselves 
to this condition. The time has come to mobilize the entire population of Uganda to join 
in this fight. Great strides have been made to decrease the effects of this epidemic. 
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Educating and involving men, women, and children creates unity and unity is absolutely 
required to eradicate this epidemic from Uganda and the planet. UNAIDS and the rest of 
the world can achieve universal access to HIV services but the next step is involving and 
engaging men in this goal. “Getting to zero” is the goal promoted by UNAIDS and with 
unity it is only a matter of time before this goal is realized.   
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Appendix 
 
A. 
 
 
Figure 1. HIV Prevalence by Region in Uganda 
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B. 
 
Figure 2. Impact of three scenarios on HIV infection in sub-Saharan Africa, 2003-2020. 
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C.  
Questionnaire for Focus Group Discussions Version 3.0 
 
Age: 
Gender: 
Married (Yes or No):  
Occupation: 
 
1. What motivated you to test for HIV? 
2. Does your partner know his/her status? 
3. Did/do you encourage your partner to get tested? 
4. Has a hospital ever insisted that you take a HIV test? If so, at when did they insist 
that you test for HIV? 
5. Why don’t more men test for HIV? 
6. How can we get more men to test for HIV? 
7. What motivated you to take antiretroviral medication? 
8. What specific antiretroviral medication do you take? 
9. What challenges do you face while taking antiretroviral medication? 
10. Do you feel that the medication is helping? Why or why not? 
11. (For men) Are you circumcised? 
a. If yes: Did you get circumcised at a hospital or using traditional means? 
b. If no: Has a hospital ever encouraged you to get circumcised?  
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D. 
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E.  
Interview Schedule for TASO Counselor at TASO Mulago Version 3.0 
1. Can you explain how the sensitization and counseling process works? 
2. Do you feel that men respond differently to these methods? 
3. Are people generally receptive to these sensitization strategies?  
4. Why is there such a lack of men engaged in antiretroviral treatment in this 
facility? 
5. What rumors do you typically have to address concerning HIV testing or ARVs? 
6. Do you think that ARVs are effective as a method of treatment? 
7. Do you find any differences between how men respond to ARVs? 
8. Do you think circumcision programs would create an avenue for men to engage in 
comprehensive HIV/AIDS care? 
9. Should laws exist that insure mandatory HIV testing for men? 
 
Interview Schedule for Dr. Simon Sentumbwe Version 3.0 
1. Why don’t more men test for HIV? 
2. How can we combat the stigma around men testing for HIV/AIDS? 
3. Can you describe in detail some past male circumcision programs? 
4. Why did these programs end? 
5. What do you think is the best strategy to better engage men in comprehensive 
HIV/AIDS services? 
6. Many clients at TASO Mulago complained about improper treatment after 
circumcision. Can you describe what they may be referring to? 
7. Should laws exist that insure mandatory HIV testing for men? 
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8. Do you think circumcision programs would create an avenue for men to engage in 
comprehensive HIV/AIDS care? 
 
Interview Schedule for Nurse at Makerere Circumcision Clinic Version 3.0 
1. Do you know how this clinic got started? 
2. Can you elaborate on your community sensitization methods? 
3. Many clients at TASO Mulago complained about improper treatment after 
circumcision. Can you describe what they may be referring to? 
4. What process does a typical client experience at this clinic? 
5. How long does the wound from circumcision take to heal? 
6. Do you test for HIV before performing the surgery? 
7. Should laws exist that insure mandatory HIV testing for men? 
8. Do you think circumcision programs would create an avenue for men to engage in 
comprehensive HIV/AIDS care? 
 
 
Interview Schedule for Pharmacist at St. Francis Naggalama Hospital Version 3.0 
 
1. How long have you worked at St. Francis Naggalama Hospital? 
2. Have ARVs changed over your duration of working here? 
3. Do you think that ARVs are effective as a method of treatment? 
4. Do you find any differences between how men respond to ARVs? 
5. Should laws exist that insure mandatory HIV testing for men? 
6. Do you think circumcision programs would create an avenue for men to engage in 
comprehensive HIV/AIDS care? 
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F. 
 
CONSENT FORM 
 
The purpose of this study is to gain a better understanding of Antiretroviral Treatment in 
Uganda, specifically how men and women respond to this treatment differently. This 
study also hopes to test the hypothesis that men initiate antiretroviral treatment later than 
women. Finally, this study will attempt to propose methods for more provider-initiated 
HIV testing for men. 
 
Rights Notice 
 
In an effort to uphold the ethical standards of all SIT ISP proposals, this study has been 
reviewed and approved by a Local Review Board or SIT Institutional Review Board. If at 
any time, you feel that you are at risk or exposed to unreasonable harm, you may 
terminate and stop the interview. Please take some time to carefully read the statements 
provided below.  
 
a. Privacy – all information you present in this interview may be recorded an 
safeguarded. If you do not want the information recorded, you need to let the 
interviewer know.  
 
b. Anonymity – all names in this study will be kept anonymous unless the 
participant chooses otherwise.  
 
 
c. Confidentiality – all names will remain completely confidential and fully 
protected by the interviewer. By signing below, you give the interviewer full 
responsibility to uphold this contract and its contents. The interviewer will 
also sign a copy of this contract and give it to the participant. 
 
       __________________________                     _____________________________ 
Participant’s name printed   Participant’s signature and date 
 
 
       __________________________                    _____________________________ 
Interviewer’s name printed   Interviewer’s signature and date 
 
 
 
For any questions or concerns please contact:  
 
Wyatt Lombard Smith    Charlotte Mafumbo 
Telephone: 0793938602     Telephone: 0794518549 
E-mail: wsmith7@nd.edu    E-mail: charlotte.mafumbo@sit.edu 
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Demographic Information from Focus Group Discussions 
Chart 1. Age Groups of Men at Each Facility 
 
 
Chart 2. Age Groups of Women at Each Facility 
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Chart 3. Percentage of Clients’ Marriage Status at Each 
Facility 
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Chart 4. Motivations for HIV Testing 
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Chart 5. Circumcision Survey 
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